Alvin V. Terry Jr., Ph.D.

photo of Terry Alvin

Dr. Alvin V. Terry Jr. is Regents Professor and the Chair of the Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University (AU), Augusta, Georgia, USA.  He is also Associate Vice President for Basic Science Research at AU, holds joint appointments as Professor of Neurology and Graduate Studies and is a licensed pharmacist in Georgia and South Carolina. 

A native of South Carolina, Dr. Terry received a B.S. in Pharmacy from the Medical University of South Carolina, Charleston, S.C. in 1982 and a Ph.D. in Pharmacology from the University of South Carolina, Columbia, S.C. in 1991.  He received post-doctoral training and served as a junior faculty member at the Medical College of Georgia (MCG) from 1991-1994, then served on the faculty of the University of Georgia (UGA) College of Pharmacy from 1994 until re-joining MCG as a Professor in 2005.   During his tenure at UGA, Dr. Terry served as a founding member, then directed the Graduate Program in Clinical and Experimental Therapeutics from 1999-2005.  Dr. Terry also created an institutional core facility at MCG, the Small Animal Behavior Core (SABC) and he has served as the Director of this facility since its inception in 2003.

To date, Dr. Terry has published 168 peer-reviewed research articles, 11 book chapters and commentaries, has presented numerous abstracts and invited seminars at national and international venues, and he holds one US patent.  His research has been continuously supported by extramural funds for more than 20 years from a variety of sources to include multiple branches of NIH (NIMH, NIA, NIEHS, NIDA), the Department of Defense (DOD), research foundations, and the pharmaceutical industry.  Dr. Terry has served on multiple study sections for a variety of governmental agencies including the NIH, NASA, the DOD and the Department of Veterans Affairs.  He has served as a scientific advisor for the Environmental Protection Agency as well as a consultant for several pharmaceutical companies and private consulting firms.  He is also the current Secretary/treasurer of the Executive Committee of the Drug Discovery and Development Division of the American Society for Pharmacology and Experimental Therapeutics (ASPET). He is also the current secretary of the Association of Medical School Pharmacology Chairs.

Dr. Terry’s research interests focus on the cognitive dysfunction associated with neuropsychiatric illnesses and exposures to environmental toxins as well as drug discovery and development strategies to treat cognitive disorders.  His laboratories employ a variety of research methods ranging from behavioral testing in animal models (rodents to non-human primates) to molecular, cellular and analytical techniques.